These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25459179)

  • 21. Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.
    Gribben JG; Hosing C; Maloney DG
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S63-70. PubMed ID: 21195313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
    Ritgen M; Böttcher S; Stilgenbauer S; Bunjes D; Schubert J; Cohen S; Humpe A; Hallek M; Kneba M; Schmitz N; Döhner H; Dreger P;
    Leukemia; 2008 Jul; 22(7):1377-86. PubMed ID: 18418404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived.
    Waselenko JK; Flynn JM; Byrd JC
    Semin Oncol; 1999 Feb; 26(1):48-61. PubMed ID: 10073561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
    Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
    Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced intensity conditioning allogeneic transplant for advanced chronic lymphocytic leukemia.
    Soligo D; Motta M; Borsotti C; Ibatici A; Cortelezzi A; Lambertenghi Deliliers G
    Haematologica; 2004 Jul; 89(7):885-6. PubMed ID: 15257953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
    Banerji V; Johnston JB; Seftel MD
    Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
    Jitawatanarat P; Desai A; Sharda P; Liu H; Ross M; Hernandez-Llizaliturri FJ; McCarthy PL; Chen GL
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1203-6. PubMed ID: 23054874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemia.
    Davids MS; Alyea EP
    Curr Hematol Malig Rep; 2015 Mar; 10(1):18-27. PubMed ID: 25682168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia.
    Santos ES; Masri M; Safah H
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):875-91. PubMed ID: 16221057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
    Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality--a single institution experience.
    Chakupurakal G; Leitzke S; Langerbeins P; Schiller J; Schneider PM; Holtick U; Shimabukuro-Vornhagen A; Theurich S; Chemnitz J; Hallek M; von Bergwelt-Baildon M; Scheid C
    Ann Hematol; 2015 Oct; 94(10):1717-25. PubMed ID: 26259502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia.
    Dreger P; Schmitz N
    Leukemia; 1997 Apr; 11 Suppl 2():S42-5. PubMed ID: 9178838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
    Kataoka I; Kami M; Takahashi S; Kodera Y; Miyawaki S; Hirabayashi N; Okamoto S; Matsumoto N; Miyazaki Y; Morishita Y; Asai O; Maruta A; Yoshida T; Imamura M; Hamajima N; Matsuo K; Harada M; Mineishi S;
    Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial).
    Montesinos P; Cabrero M; Valcárcel D; Rovira M; García-Marco JA; Loscertales J; Moreno C; Duarte R; Terol MJ; Villamor N; Abrisqueta P; Caballero D; Sanz J; Delgado J
    Bone Marrow Transplant; 2016 Oct; 51(10):1404-1407. PubMed ID: 27214073
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Brunner AM; Kim HT; Coughlin E; Alyea EP; Armand P; Ballen KK; Cutler C; Dey BR; Glotzbecker B; Koreth J; McAfee SL; Spitzer TR; Soiffer RJ; Antin JH; Ho VT; Chen YB
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1374-80. PubMed ID: 23791626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation in chronic lymphocytic leukemia: timing and expectations.
    Hallam S; Gribben JG
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S186-93. PubMed ID: 19778839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia.
    Gribben JG
    J Clin Oncol; 2008 Oct; 26(30):4864-5. PubMed ID: 18794537
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.